MRNA shares have maintained a positive posture in terms of Ichimoku Cloud trend bearing, with plenty of room to go on the upside according to recent RSI peaks. That said, this is a Biotech, which means technicals only indicate a small piece of the story, dwarfed by potential headlines still to come.
Moderna, Inc. (MRNA) – after 3 weeks of correction and consolidation period the stock broke out of a bullish pennant today and retested resistance in the 65 area which if broken in the coming days could lead to new momentum with the target in the 80-85 range. Initial stop loss 57.5.
Looking at a possible bullish breakout via Symmetrical Wedge if market and news behave. Support between 47-51 and possible resistance between 65-70.
Are you looking at Price changes? Moves over time? What is it you want to see...? Stuck with Candles looking for patterns? Renko Blocks Henken-Ashi Kagi
Hi Guys, Another easy day in the market with 3 for 3 wins. We are designing a trading course at the moment which will teach you how to go from zero knowledge to trading profitable in the chat room with us! Enjoy, Enda
May's monthly candle closed above April's high. If price returns to April's high, then I will begin purchasing call options at the 56.00 strike with a July 2 expiration.
$MRNA Bullish falling wedge Resistance: 65.16 Support: 47.56 Buy: $56.40 Stop loss: $50.99 Limit sell: $63.90 Notes: Still feel sketch about their "Secondary offering" it tells shareholders that they are going to take a giant ass pile of cash and set it on fire. However, as will all offerings... someone has to make money so you can decide if it is worth a...
MRNA may have seen a climax in trend strength on the gap run earlier this month when it leaked positive but vague vaccine data and then dropped a secondary on the market. We saw an RSI bear divergence after all-time high oscillator readings. And now, we are flirting with a primary trendline break.
Pretty Obvious that this is WAY beyond the BB std dev. for 4 days in a row and likely to revert to the mean of at least $60.
Recent $MRNA preliminary COVID-19 vaccine data-induced rally created a gap between $66-75 range. Gap close starting to occur as RSI indicates overbought condition. .618 Fibonacci @ $60~. Short target: $60-62.
$MRNA is a good mover, presenting a case to buy on the morning panic dip which happens almost (keyword almost) religiously around 10:45-10:55am. Probably 1 out of 5 days, this morning dip buy setup doesn't work, in which case I would just cut the trade short.
I missed this guy when I jumped on MRNA and INO earlier this week. Just trying to pin this one down a bit, coronavirus stocks are wild and fun :). For FOMO stocks, typical support and resistance horizontal lines aren't as predictive and you should instead look to the Volume Profile. Support should be right around the POC, which is $40. It should slide down to...
Many people are interested in the question, will the shares of Moderna (MRNA) go even higher or not? After all, not so long ago, they were able to show growth of more than 300% in a few months! I will tell you this - if you prefer systematic trading and open your trades on signals, it is not clear at the moment (so we chose a neutral or observational idea). But...
Nothing too serious here, just an observer on this one. One of my biggest regrets, I pumped money into INO instead of MRNA when they were both cheap when the smart play was covering the field. Noob move... alas, there's always another stock to chase. Anyway, here's a decent stock architecture for anyone playing this. Basically I'm just hoping it dips super low...
nice broadening formation here.. can rip to 81 if it gets 72
I know the news about Moderna is hype right now but technicals are showing a bearish divergence from the RSI. Based on the "Lazy Elliott" Forecast, if you're going to assume this plot to be an impulse wave, wave 3 from this perspective might be complete already. One way to verify is if the price closes below the 161.8% level, it might signal the start of wave...
First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. Moderna's Covid19 vaccine for mRNA-1273 is reaching Phase 2 clinical trails by the FDA which is further ahead than most of its small competitors and bio-pharmaceutical corporations. As always, you see the big giant crushing the small one. This...
One of the leaders on cracking Vacine Jumping through all the Hoops Dr Fauci says it looks good plenty of funding like 400 mill plus and heaps in the bank pulling out all the stops to be first.